Vemlidy 25 mg film-coated tablets

DRUG3 trials

Sponsors

Antwerp University Hospital, ANRS Maladies Infectieuses Emergentes, Helse Bergen HF

Conditions

Chronic hepatitis B infectionEpstein-Barr virus infectionHBV

Phase 2

ANRS HB07 IP-Cure-B proof of concept (PoC) clinical trial. Educating the liver immune environment through TLR8 stimulation followed by NUC discontinuation.

Active, not recruitingCTIS2024-515739-32-00

ANRS Maladies Infectieuses EmergentesHBV

Start: 2022-01-10Target: 51Updated: 2025-12-31

Controlled Interruption of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Infections

Active, not recruitingCTIS2024-511016-25-00

Antwerp University HospitalChronic hepatitis B infection

Start: 2025-01-15Target: 140Updated: 2025-01-15

Dosing EvaLuation of Tenofovir Alafenamide on Epstein-Barr Virus (The DELTA-EBV study)

Not yet recruitingCTIS2025-522781-77-01

Helse Bergen HFEpstein-Barr virus infection

Target: 45Updated: 2026-05-28